aromasin cuts risk of breast cancer in some groups
the estrogen-blocker aromasin was found to reduce the risk of developing breast cancer by 65 percent in post-menopausal women at high risk for breast cancer, researchers said on saturday.
http://feeds.reuters.com/~r/reuters/healthnews/~3/sq0d8abfhqq/us-cancer-breast-pfizer-idustre7531jt20110604
12692
04 Jun 2011 20:49:41
reuters
health